✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Kwality Pharmaceuticals Ltd.

KPL

Market Cap
₹827 Cr.
P/E
27.83

Kwality Pharmaceuticals Ltd.

  • Kwality Pharma
  • Wanbury
  • Anuh Pharma
FAQs on Kwality Pharmaceuticals Ltd. Shareprice

Kwality Pharma has given lower returns compared to its competitors.
Kwality Pharma has grown at ~16.51% over the last 3yrs while peers have grown at a median rate of 19.8%

Yes, Kwality Pharma is expensive.
Latest PE of Kwality Pharma is 27.83, while 3 year average PE is 24.98.
Also latest EV/EBITDA of Kwality Pharma is 12.27 while 3yr average is 7.39.

View FAQ's On Business
Growth Table
  • Kwality Pharmaceuticals Ltd.
  • Wanbury
  • Anuh Pharma
Balance Sheet
  • Kwality Pharmaceuticals Ltd.
  • Wanbury
  • Anuh Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Kwality Pharmaceuticals Ltd.
  • Wanbury
  • Anuh Pharma
Cash Flow
  • Kwality Pharmaceuticals Ltd.
  • Wanbury
  • Anuh Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Kwality Pharmaceuticals Ltd.
  • Wanbury
  • Anuh Pharma
Quarterly Results
  • Kwality Pharmaceuticals Ltd.
  • Wanbury
  • Anuh Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Kwality Pharmaceuticals Ltd. Financials

Balance sheet of Kwality Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Kwality Pharma is increasing.
Latest debt of Kwality Pharma is ₹94.75 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹86.39 Crs.

Yes, profit is increasing.
The profit of Kwality Pharma is ₹29.56 Crs for TTM, ₹23.8 Crs for Mar 2024 and ₹19.37 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Kwality Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech